Financials Xtant Medical Holdings, Inc.
Equities
XTNT
US98420P3082
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8103 USD | +0.04% | -4.67% | -28.29% |
04-30 | Xtant Medical Holdings, Inc. Announces Launch of SimpliGraft and SimpliMax for Chronic and Acute Wounds | CI |
04-01 | Xtant Medical Files $150 Million Mixed Shelf; Shares Fall | MT |
Valuation
Fiscal Period: December | 2019 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 21.06 | 71.72 | 147 | 105.5 | - | - |
Enterprise Value (EV) 1 | 21.06 | 71.72 | 147 | 105.5 | 105.5 | 105.5 |
P/E ratio | -2.58 x | -7.33 x | 113 x | -13.5 x | -162 x | 40.5 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.33 x | - | 1.61 x | 0.92 x | 0.81 x | 0.67 x |
EV / Revenue | 0.33 x | - | 1.61 x | 0.92 x | 0.81 x | 0.67 x |
EV / EBITDA | 5.44 x | - | 142 x | 21.1 x | 8.79 x | - |
EV / FCF | - | - | -13.4 x | -26.4 x | 23.4 x | - |
FCF Yield | - | - | -7.46% | -3.79% | 4.26% | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 13,162 | 108,659 | 130,110 | 130,217 | - | - |
Reference price 2 | 1.600 | 0.6600 | 1.130 | 0.8103 | 0.8103 | 0.8103 |
Announcement Date | 20-03-05 | 23-03-07 | 24-04-01 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | 64.68 | - | 91.3 | 115 | 130.4 | 157 |
EBITDA 1 | 3.869 | - | 1.038 | 5 | 12 | - |
EBIT 1 | -2.253 | - | -10.16 | -6.85 | 0.5 | 5 |
Operating Margin | -3.48% | - | -11.13% | -5.96% | 0.38% | 3.18% |
Earnings before Tax (EBT) 1 | -8.123 | - | -1.037 | -8.3 | -0.9 | 5 |
Net income 1 | -8.221 | -8.485 | 0.66 | -8.3 | -0.9 | 4 |
Net margin | -12.71% | - | 0.72% | -7.22% | -0.69% | 2.55% |
EPS 2 | -0.6200 | -0.0900 | 0.0100 | -0.0600 | -0.005000 | 0.0200 |
Free Cash Flow 1 | - | - | -10.97 | -4 | 4.5 | - |
FCF margin | - | - | -12.02% | -3.48% | 3.45% | - |
FCF Conversion (EBITDA) | - | - | - | - | 37.5% | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 20-03-05 | 23-03-07 | 24-04-01 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 17.94 | 20.23 | 25.02 | 28.11 | 25.77 | 27.91 | 29.07 | 32.24 | 28.94 |
EBITDA 1 | -0.29 | 0.101 | 0.452 | 0.761 | 0.377 | 1.035 | 1.692 | 1.915 | 2.293 |
EBIT 1 | -1.576 | -1.391 | -3.385 | -3.806 | -1.95 | -1.6 | -1.5 | -1.85 | -0.35 |
Operating Margin | -8.78% | -6.88% | -13.53% | -13.54% | -7.57% | -5.73% | -5.16% | -5.74% | -1.21% |
Earnings before Tax (EBT) 1 | -2.065 | -2.177 | 6.931 | -3.726 | -2.3 | -1.95 | -1.85 | -2.2 | -0.7 |
Net income 1 | -2.078 | -2.19 | 9.231 | -4.303 | -2.3 | -1.95 | -1.85 | -2.2 | -0.7 |
Net margin | -11.58% | -10.82% | 36.9% | -15.31% | -8.93% | -6.99% | -6.36% | -6.82% | -2.42% |
EPS 2 | -0.0200 | -0.0200 | 0.0700 | -0.0300 | -0.0150 | -0.0150 | -0.0100 | -0.0150 | -0.005000 |
Dividend per Share | - | - | - | - | - | - | - | - | - |
Announcement Date | 23-05-04 | 23-08-01 | 23-11-09 | 24-04-01 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -11 | -4 | 4.5 | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | - | 1.46 | 3 | 2 | - |
Capex / Sales | - | - | 1.59% | 2.61% | 1.53% | - |
Announcement Date | 20-03-05 | 23-03-07 | 24-04-01 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.29% | 105M | |
+10.39% | 126B | |
-6.86% | 10.93B | |
+2.52% | 9.11B | |
+38.96% | 5.42B | |
-17.50% | 5.18B | |
+8.36% | 3.44B | |
-8.84% | 2.8B | |
-7.52% | 2.25B | |
-3.00% | 2.21B |
- Stock Market
- Equities
- XTNT Stock
- Financials Xtant Medical Holdings, Inc.